Literature DB >> 18242505

Vanishing bile duct syndrome.

Nancy S Reau1, Donald M Jensen.   

Abstract

Perhaps no condition associated with chronic cholestasis is less understood than vanishing bile duct syndrome, a term that refers loosely to the group of acquired disorders associated with progressive destruction and disappearance of the intrahepatic bile ducts and, ultimately, cholestasis. Although the array of insults resulting in poor bile flow is vast, most adult patients who have chronic cholestasis have either primary biliary cirrhosis (or primary sclerosing cholangitis; in some cases, however, a cause cannot be identified. This article reviews the multiple causes, postulated pathophysiology, clinical features, and treatment options for this syndrome.

Entities:  

Mesh:

Year:  2008        PMID: 18242505     DOI: 10.1016/j.cld.2007.11.007

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  30 in total

Review 1.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

2.  Impact of magnetic resonance cholangiography in managing liver-transplanted patients: preliminary results of a clinical decision-making study.

Authors:  L Cereser; R Girometti; G Como; C Molinari; P Toniutto; D Bitetto; C Zuiani; M Bazzocchi
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

3.  Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements.

Authors:  Herbert L Bonkovsky; David E Kleiner; Jiezhun Gu; Joseph A Odin; Mark W Russo; Victor M Navarro; Robert J Fontana; Marwan S Ghabril; Huiman Barnhart; Jay H Hoofnagle
Journal:  Hepatology       Date:  2017-02-07       Impact factor: 17.425

4.  Clinical and histologic features of azithromycin-induced liver injury.

Authors:  Melissa A Martinez; Raj Vuppalanchi; Robert J Fontana; Andrew Stolz; David E Kleiner; Paul H Hayashi; Jiezhun Gu; Jay H Hoofnagle; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-09       Impact factor: 11.382

5.  Vanishing bile duct syndrome in human immunodeficiency virus: nevirapine hepatotoxicity revisited.

Authors:  Rajan Kochar; Moises I Nevah; Frank J Lukens; Michael B Fallon; Victor I Machicao
Journal:  World J Gastroenterol       Date:  2010-07-14       Impact factor: 5.742

6.  Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases.

Authors:  Ana Paula Oppenheimer; Christopher Koh; Mary McLaughlin; John C Williamson; Thomas D Norton; Jennifer Laudadio; Theo Heller; David E Kleiner; Kevin P High; Caryn G Morse
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

7.  Vanishing Bile Duct Syndrome in Hodgkin's Lymphoma: A Single Center Experience and Clinical Pearls.

Authors:  Mena Bakhit; Thomas R McCarty; Sunhee Park; Basile Njei; Margaret Cho; Raffi Karagozian; AnnMarie Liapakis
Journal:  J Clin Gastroenterol       Date:  2016-09       Impact factor: 3.062

Review 8.  Infliximab/Plasmapheresis in vanishing bile duct syndrome secondary to toxic epidermal necrolysis.

Authors:  Jason C White; Stephanie Appleman
Journal:  Pediatrics       Date:  2014-09-22       Impact factor: 7.124

9.  Bile duct paucity in childhood-spectrum, profile, and outcome.

Authors:  Babu Lal Meena; Rajeev Khanna; Chhagan Bihari; Archana Rastogi; Dinesh Rawat; Seema Alam
Journal:  Eur J Pediatr       Date:  2018-06-04       Impact factor: 3.183

10.  Successful liver transplantation for drug-induced vanishing bile duct syndrome.

Authors:  Ahmed Hashim; Ashley Barnabas; Rosa Miquel; Kosh Agarwal
Journal:  BMJ Case Rep       Date:  2020-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.